local_hospital

Hopital Antoine Beclere

Address
lock Available on a paid plan

Infectious Diseases and HIV Research

At Hopital Antoine Beclere in the paediatric emergency setting, clinical trials in infectious diseases focus on HIV and respiratory viral infections. These studies are designed to test new treatment strategies, improve prevention, and support better long-term control of infection in both children and families.

  • Evaluating new approaches to achieve better HIV remission and maintain viral suppression
  • Testing prevention strategies for respiratory syncytial virus infection in infants
  • Assessing treatments aimed at reducing the impact of respiratory tract infection

Overall, this research combines therapeutic innovation with practical prevention goals, especially for vulnerable newborns and infants.

Maternal, Fetal, and Neonatal Health

Trials in maternal and neonatal health address conditions such as pregnancy associated hypertension, pre-eclampsia, fetal growth restriction, and prematurity in neonates. The aim is to improve pregnancy outcomes, reduce complications before and after birth, and support safer care for mothers and babies.

  • Studying ways to prevent serious pregnancy complications and improve maternal-fetal outcomes
  • Testing interventions to lower the risk of preterm delivery and related newborn problems
  • Evaluating prevention strategies for respiratory illness in early infancy

This area reflects a strong focus on early-life health, with research intended to improve both obstetric care and neonatal survival.

Pediatric Emergency and Pain Management

The site also contributes to pediatric emergency research, including studies on vaso-occlusive crisis due to sickle cell disease. These trials aim to improve rapid pain relief and strengthen emergency treatment for children with severe acute symptoms.

  • Testing better pain control for children with sickle cell disease in emergency care
  • Comparing treatment approaches to improve the speed and quality of analgesia
  • Supporting more effective care for acute pediatric crises

Research in this field is directly relevant to urgent care settings, where faster and more effective symptom relief can make a major difference.

Oncology and Fertility Preservation

Clinical research in neoplasms includes breast cancer, especially in younger women and older patients with hormone-sensitive disease. The studies examine both treatment effectiveness and the preservation of fertility before cancer therapy begins.

  • Evaluating oocyte and embryo cryopreservation for young women facing cancer treatment
  • Assessing whether additional cancer treatment improves survival in selected older patients
  • Studying treatment strategies for ER-positive HER2-negative breast carcinoma

This research combines cancer care with quality-of-life concerns, including future fertility and personalized treatment decisions.

Rare Metabolic and Genetic Disorders

Trials in metabolism and congenital, hereditary, and neonatal diseases include glycogen storage disease type 1a. The research is focused on testing innovative therapies that may improve disease control and safety for patients with rare inherited conditions.

  • Exploring a new treatment approach for GSD1a
  • Assessing safety and tolerability in a rare pediatric genetic disorder
  • Supporting development of more targeted options for inherited metabolic disease

These studies highlight the site’s involvement in advancing care for uncommon conditions where treatment choices remain limited.

Respiratory and Neonatal Lung Disease

Another important focus is respiratory tract disease in newborns, particularly bronchopulmonary dysplasia and bronchiolitis. The trials aim to improve prevention and reduce the burden of lung disease in high-risk infants.

  • Evaluating therapies intended to lower the risk of bronchopulmonary dysplasia in preterm neonates
  • Studying prevention of bronchiolitis and other early respiratory infections
  • Improving outcomes for infants vulnerable to severe breathing problems

At this hospital, the neonatal respiratory portfolio centers on protecting lung health during the earliest stages of life.

Women’s Health and Pregnancy-Related Infection

Research in female urogenital disease includes preterm prelabor rupture of membranes and related infectious complications. These studies are designed to improve maternal and neonatal outcomes by finding better ways to prevent infection and reduce perinatal risk.

  • Comparing antibiotic strategies for PPROM in late second and early third trimester pregnancies
  • Studying ways to reduce perinatal morbi-mortality
  • Supporting safer care for pregnancies complicated by membrane rupture

This work reflects a broader commitment to improving obstetric care through evidence-based prevention and treatment.

Behavioral Health and Smoking Cessation

The site also includes research in psychiatry and psychology, especially behavior and behavior mechanisms linked to smoking cessation. These trials aim to help people stop smoking by comparing different cessation tools and support strategies.

  • Testing whether electronic cigarettes can support quitting smoking
  • Comparing nicotine-containing and nicotine-free options with established cessation treatment
  • Evaluating practical approaches to changing tobacco-use behavior

Although less central than the pediatric studies, this research adds a behavioral health dimension to the site’s clinical trial portfolio.

Hematology and Blood Disorders

Clinical research in hemic and lymphatic diseases includes care for sickle cell disease. The main goal is to improve symptom relief and emergency management for acute painful episodes in children.

  • Improving treatment of severe vaso-occlusive crisis
  • Studying faster and more effective pain management in emergency care
  • Supporting better outcomes for children with inherited blood disorders

This area shows how the paediatric emergency department contributes to urgent care research with direct clinical relevance.

Health Care Organization and Prevention Research

Some studies at Hopital Antoine Beclere also touch on health care economics and organizations, reflecting work that aims to improve how preventive care is delivered and used in real-world settings. These trials look at practical ways to organize care for mothers, newborns, and other at-risk groups.

  • Assessing prevention strategies for infections and pregnancy complications
  • Supporting more efficient use of existing care pathways
  • Evaluating approaches that may improve access and outcomes in routine practice

This adds a system-level perspective to the site’s broader clinical research activity.

Site Overview

assignment
11
connected trials
corporate_fare
11
sponsors
science
27
IMPs

Activity Indicator

Last 6 months

1
Trials started
-50% vs previous period.
2
Trials started 6–12 months ago
11
Total trials linked
Highly Active
trending_downDeclining-50%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 9 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
8
Sponsors (total)
11
Active sponsors
8

Sponsor Network

Top 8 by active trials.

lock +7 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
11
Outperforms 75% of sites
public
Therapeutic diversity
11areas
Outperforms 86% of sites
groups
Sponsor diversity
11sponsors
Outperforms 78% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Hopital Antoine Beclere

lock Showing 1 of 11 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Nicotine-Containing Electronic Cigarettes, Varenicline, and Nicotine-Free Electronic Cigarettes in SmokersAssistance Publique Hopitaux De ParisPhase IIINot Yet RecruitingOct 2024

IMP list

lock Showing 1 of 27 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Sodium Chloride2Unknown2024-06-202025-07-21

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.